表观遗传修饰与环状RNA在结直肠癌中相互作用的研究进展

doi:10.3969/j.issn.1674-8115.2023.02.014

摘要/Abstract

摘要：

结直肠癌（colorectal cancer，CRC）是全球第三大常见的恶性肿瘤，目前针对该病的诊断和治疗方法都存在局限性。既往的研究表明，表观遗传修饰在结直肠癌的进展中发挥了重要作用。表观遗传修饰是指基因功能在DNA序列不变的情况下发生了可遗传的变化，导致相似DNA的细胞最终发育成具有不同功能的细胞，其中主要包括DNA/RNA甲基化修饰、组蛋白修饰、非编码RNA转录后调控等。环状RNA（circular RNA，circRNA）是非编码RNA中的一种具有稳定环状结构的RNA分子，广泛存在于多种细胞中，且可以通过多种通路影响肿瘤的进展。目前许多研究表明表观遗传修饰可以影响circRNA的生物学功能，而circRNA也能通过靶向表观遗传修饰相关分子参与结直肠癌的进展。其中，研究发现一方面N⁶-甲基腺苷（N⁶-methyladenosine，m⁶A）可以直接影响circRNA的生成、翻译及功能，另一方面circRNA也可以调控m⁶A修饰及其调节因子，从而影响疾病的发生发展及转移。DNA甲基化和组蛋白修饰也与circRNA有潜在的相互作用。该文描述了表观遗传修饰与circRNA在结直肠癌中的相互作用，以及它们在癌症发展中的作用，并提出了它们在诊断与治疗中的潜在应用和未来研究方向。

关键词: 环状RNA, 结直肠癌, N⁶-甲基腺苷, DNA甲基化, 组蛋白修饰

Abstract:

Colorectal cancer (CRC) is generally regarded as the third frequent malignancy worldwide, while current diagnosis and treatment of the disease are limited. The previous studies of CRC revealed that epigenetic modification plays a crucial role in the progression of CRC. Epigenetic modification is identified as heritable changes in gene functions that occur without changing the DNA sequence, resulting in cells with similar DNA eventually developing into different types with different functions, which encompasses DNA/RNA methylation, histone modification, and non-coding RNA regulation. Circular RNA (circRNA), a kind of non-coding RNA that forms a covalently closed loop, is widely present in various cells which drive initiation and progression of cancers through multiple pathways. The emerging data show that epigenetic modification may affect the biological functions of circRNA, while circRNA can also participate in the progression of CRC by targeting molecules related to epigenetic modification. N⁶-methyladenosine (m⁶A) has been found to directly promote production, translation, and functions of circRNA on the one hand, and interact with circRNA on the other hand, thereby altering onset, progression, and metastasis of the disease. DNA methylation and histone modification have also been observed to have potential interaction with circRNA. This review provides a brief overview about the association between current epigenetic modifications and circRNA, and the significant role they may play in the progression of CRC, and also outlines the potential applications to diagnosis and treatment, and the research direction in the future.

Key words: circular RNA (circRNA), colorectal cancer (CRC), N⁶?methyladenosine (m⁶A), DNA methylation, histone modification

中图分类号:

R735.3

彭恬, 徐雷鸣. 表观遗传修饰与环状RNA在结直肠癌中相互作用的研究进展[J]. 上海交通大学学报（医学版）, 2023, 43(2): 237-243.

PENG Tian, XU Leiming. Crosstalk between epigenetic modification and circRNA in colorectal cancer: recent advances[J]. Journal of Shanghai Jiao Tong University (Medical Science), 2023, 43(2): 237-243.

参考文献 48

1	GOEL A, BOLAND C R. Epigenetics of colorectal cancer[J]. Gastroenterology, 2012, 143(6): 1442-1460.e1.
2	CAVALLI G, HEARD E. Advances in epigenetics link genetics to the environment and disease[J]. Nature, 2019, 571(7766): 489-499.
3	ZHANG Z, WANG Q, ZHANG M M, et al. Comprehensive analysis of the transcriptome-wide m⁶A methylome in colorectal cancer by MeRIP sequencing[J]. Epigenetics, 2021, 16(4): 425-435.
4	ANASTASIADOU E, JACOB L S, SLACK F J. Non-coding RNA networks in cancer[J]. Nat Rev Cancer, 2018, 18(1): 5-18.
5	HAO S H, CONG L, QU R F, et al. Emerging roles of circular RNAs in colorectal cancer[J]. Onco Targets Ther, 2019, 12: 4765-4777.
6	GUO Y X, GUO Y Y, CHEN C, et al. Circ3823 contributes to growth, metastasis and angiogenesis of colorectal cancer: involvement of miR-30c-5p/TCF7 axis[J]. Mol Cancer, 2021, 20(1): 93.
7	LIU X, LIU Y Z, LIU Z, et al. CircMYH9 drives colorectal cancer growth by regulating serine metabolism and redox homeostasis in a p53-dependent manner[J]. Mol Cancer, 2021, 20(1): 114.
8	CHEN L Y, WANG L, REN Y X, et al. The circular RNA circ-ERBIN promotes growth and metastasis of colorectal cancer by miR-125a-5p and miR-138-5p/4EBP-1 mediated cap-independent HIF-1α translation[J]. Mol Cancer, 2020, 19(1): 164.
9	JIANG T, WANG H Y, LIU L Y, et al. CircIL4R activates the PI3K/AKT signaling pathway via the miR-761/TRIM29/PHLPP1 axis and promotes proliferation and metastasis in colorectal cancer[J]. Mol Cancer, 2021, 20(1): 167.
10	WANG J Q, ZHANG Y, SONG H, et al. The circular RNA circSPARC enhances the migration and proliferation of colorectal cancer by regulating the JAK/STAT pathway[J]. Mol Cancer, 2021, 20(1): 81.
11	ESTELLER M, PANDOLFI P P. The epitranscriptome of noncoding RNAs in cancer[J]. Cancer Discov, 2017, 7(4): 359-368.
12	CHEN C, GUO Y Y, GUO Y X, et al. m⁶A modification in non-coding RNA: the role in cancer drug resistance[J]. Front Oncol, 2021, 11: 746789.
13	FU Y, DOMINISSINI D, RECHAVI G, et al. Gene expression regulation mediated through reversible m⁶A RNA methylation[J]. Nat Rev Genet, 2014, 15(5): 293-306.
14	ZACCARA S, RIES R J, JAFFREY S R. Reading, writing and erasing mRNA methylation[J]. Nat Rev Mol Cell Biol, 2019, 20(10): 608-624.
15	LI T, HU P S, ZUO Z X, et al. METTL3 facilitates tumor progression via an m⁶A-IGF2BP2-dependent mechanism in colorectal carcinoma[J]. Mol Cancer, 2019, 18(1): 112.
16	NOMBELA P, MIGUEL-LÓPEZ B, BLANCO S. The role of m⁶A, m⁵C and Ψ RNA modifications in cancer: novel therapeutic opportunities[J]. Mol Cancer, 2021, 20(1): 18.
17	ZHOU C, MOLINIE B, DANESHVAR K, et al. Genome-wide maps of m⁶A circRNAs identify widespread and cell-type-specific methylation patterns that are distinct from mRNAs[J]. Cell Rep, 2017, 20(9): 2262-2276.
18	YANG Y, FAN X J, MAO M W, et al. Extensive translation of circular RNAs driven by N⁶-methyladenosine[J]. Cell Res, 2017, 27(5): 626-641.
19	MENG E Q, DENG J, JIANG R Q, et al. CircRNA-encoded peptides or proteins as new players in digestive system neoplasms[J]. Front Oncol, 2022, 12: 944159.
20	LI Y, CHEN B, ZHAO J J, et al. HNRNPL circularizes ARHGAP35 to produce an oncogenic protein[J]. Adv Sci (Weinh), 2021, 8(13): 2001701.
21	KONSAVAGE W M Jr, KYLER S L, RENNOLL S A, et al. Wnt/β- catenin signaling regulates Yes-associated protein (YAP) gene expression in colorectal carcinoma cells[J]. J Biol Chem, 2012, 287(15): 11730-11739.
22	CHEN C, YUAN W T, ZHOU Q B, et al. N⁶-methyladenosine-induced circ1662 promotes metastasis of colorectal cancer by accelerating YAP1 nuclear localization[J]. Theranostics, 2021, 11(9): 4298-4315.
23	WANG Q, CHEN C, DING Q Q, et al. METTL3-mediated m⁶A modification of HDGF mRNA promotes gastric cancer progression and has prognostic significance[J]. Gut, 2020, 69(7): 1193-1205.
24	VO J N, CIESLIK M, ZHANG Y J, et al. The landscape of circular RNA in cancer[J]. Cell, 2019, 176(4): 869-881.e13.
25	SHIMA H, MATSUMOTO M, ISHIGAMI Y, et al. S-adeno-sylmethionine synthesis is regulated by selective N⁶-adenosine methylation and mRNA degradation involving METTL16 and YTHDC1[J]. Cell Rep, 2017, 21(12): 3354-3363.
26	PARK O H, HA H, LEE Y, et al. Endoribonucleolytic cleavage of m⁶A-containing RNAs by RNase P/MRP complex[J]. Mol Cell, 2019, 74(3): 494-507.e8.
27	KRISTENSEN L S, JAKOBSEN T, HAGER H, et al. The emerging roles of circRNAs in cancer and oncology[J]. Nat Rev Clin Oncol, 2022, 19(3): 188-206.
28	LIN C W, MA M, ZHANG Y, et al. The N⁶-methyladenosine modification of circALG1 promotes the metastasis of colorectal cancer mediated by the miR-342-5p/PGF signalling pathway[J]. Mol Cancer, 2022, 21(1): 80.
29	CHEN R X, CHEN X, XIA L P, et al. N⁶-methyladenosine modification of circNSUN2 facilitates cytoplasmic export and stabilizes HMGA2 to promote colorectal liver metastasis[J]. Nat Commun, 2019, 10(1): 4695.
30	BAI Y, YANG C X, WU R L, et al. YTHDF1 regulates tumorigenicity and cancer stem cell-like activity in human colorectal carcinoma[J]. Front Oncol, 2019, 9: 332.
31	JIANG Z P, HOU Z H, LIU W, et al. Circular RNA protein tyrosine kinase 2 (circPTK2) promotes colorectal cancer proliferation, migration, invasion and chemoresistance[J]. Bioengineered, 2022, 13(1): 810-823.
32	YAO B, ZHANG Q L, YANG Z, et al. CircEZH2/miR-133b/IGF2BP2 aggravates colorectal cancer progression via enhancing the stability of m⁶A-modified CREB1 mRNA[J]. Mol Cancer, 2022, 21(1): 140.
33	LAO V V, GRADY W M. Epigenetics and colorectal cancer[J]. Nat Rev Gastroenterol Hepatol, 2011, 8(12): 686-700.
34	MOORE L D, LE T, FAN G P. DNA methylation and its basic function[J]. Neuropsychopharmacology, 2013, 38(1): 23-38.
35	JONES P A, BAYLIN S B. The fundamental role of epigenetic events in cancer[J]. Nat Rev Genet, 2002, 3(6): 415-428.
36	FERREIRA H J, DAVALOS V, DE MOURA M C, et al. Circular RNA CpG island hypermethylation-associated silencing in human cancer[J]. Oncotarget, 2018, 9(49): 29208-29219.
37	MAO G L, ZHOU B, XU W Q, et al. Hsa_circ_0040809 regulates colorectal cancer development by upregulating methyltransferase DNMT1 via targeting miR-515-5p[J]. J Gene Med, 2021, 23(12): e3388.
38	HAN G D, WEI Z J, CUI H B, et al. NUSAP1 gene silencing inhibits cell proliferation, migration and invasion through inhibiting DNMT1 gene expression in human colorectal cancer[J]. Exp Cell Res, 2018, 367(2): 216-221.
39	GU Y, CI C, ZHANG X D, et al. Prediction of circRNAs based on the DNA methylation-mediated feature sponge function in breast cancer[J]. Front Bioeng Biotechnol, 2019, 7: 365.
40	CHEN N F, ZHAO G, YAN X, et al. A novel FLI1 exonic circular RNA promotes metastasis in breast cancer by coordinately regulating TET1 and DNMT1[J]. Genome Biol, 2018, 19(1): 218.
41	ZHANG B G, YANG S, WANG J P. Circ_0084615 is an oncogenic circular RNA in colorectal cancer and promotes DNMT3A expression via repressing miR-599[J]. Pathol Res Pract, 2021, 224: 153494.
42	LUGER K, MÄDER A W, RICHMOND R K, et al. Crystal structure of the nucleosome core particle at 2.8 Å resolution[J]. Nature, 1997, 389(6648): 251-260.
43	CZERMIN B, MELFI R, MCCABE D, et al. Drosophila enhancer of Zeste/ESC complexes have a histone H3 methyltransferase activity that marks chromosomal Polycomb sites[J]. Cell, 2002, 111(2): 185-196.
44	WANG Y, XUAN Z Q, WANG B C, et al. Hsa_circ_0071589 promotes carcinogenesis via the miR-600/EZH2 axis in colorectal cancer[J]. Biomedecine Pharmacother, 2018, 102: 1188-1194.
45	CHEN L Y, ZHI Z, WANG L, et al. NSD2 circular RNA promotes metastasis of colorectal cancer by targeting miR-199b-5p-mediated DDR1 and JAG1 signalling[J]. J Pathol, 2019, 248(1): 103-115.
46	HOLDT L M, KOHLMAIER A, TEUPSER D. Circular RNAs as therapeutic agents and targets[J]. Front Physiol, 2018, 9: 1262.
47	GE L C, ZHANG N, CHEN Z J, et al. Level of N⁶-methyladenosine in peripheral blood RNA: a novel predictive biomarker for gastric cancer[J]. Clin Chem, 2020, 66(2): 342-351.
48	BELTRÁN-GARCÍA J, OSCA-VERDEGAL R, MENA-MOLLÁ S, et al. Epigenetic IVD tests for personalized precision medicine in cancer[J]. Front Genet, 2019, 10: 621.

[1]	吴佳晋, 钟晨, 李大伟, 陈若洋, 瞿俊文, 张明. 甲基转移酶3调控pri-miR-21甲基化修饰在糖尿病肾病肾脏纤维化中的作用[J]. 上海交通大学学报（医学版）, 2023, 43(1): 1-7.
[2]	胡慕妮, 季林华, 张昕雨, 沈超琴, 洪洁, 陈豪燕. 结直肠癌组织T细胞受体组库多样性与患者临床特征和具核梭形杆菌丰度的关联分析[J]. 上海交通大学学报（医学版）, 2022, 42(8): 1045-1052.
[3]	邱佳辉, 蔡谦谦, 杨彦, 程非池, 裘正军, 黄陈. 神经脉管浸润联合肿瘤间质比对结直肠癌预后的预测价值[J]. 上海交通大学学报（医学版）, 2022, 42(8): 1070-1080.
[4]	赵敏, 褚以忞, 彭海霞. 结直肠癌和结直肠腺瘤筛查方式的研究进展[J]. 上海交通大学学报（医学版）, 2022, 42(5): 673-679.
[5]	龚其雨, 陈磊. 多组学数据解析循环及浸润性B细胞在结直肠癌免疫微环境中的作用[J]. 上海交通大学学报（医学版）, 2022, 42(4): 472-481.
[6]	陈威存, 苑影, 柯碧莲. 近视相关非编码RNA的研究进展[J]. 上海交通大学学报（医学版）, 2022, 42(3): 369-374.
[7]	赵久红, 童佳婷, 沈郅珺, 吕叶辉. 环状RNA与氧化应激互作机制的研究进展[J]. 上海交通大学学报（医学版）, 2022, 42(3): 393-399.
[8]	徐莹, 褚以忞, 杨大明, 李吉, 张海芹, 彭海霞. 基于差异表达基因组合构建高度微卫星不稳定结直肠癌转移预测模型[J]. 上海交通大学学报(医学版), 2021, 41(9): 1197-1206.
[9]	成英杰, 孙倩倩, 赵敏. 甲基苯丙胺使用和成瘾的表观遗传研究进展[J]. 上海交通大学学报(医学版), 2021, 41(8): 1094-1098.
[10]	吴丹, 葛莉萍. 妊娠期糖尿病患者基因DNA甲基化的研究进展[J]. 上海交通大学学报(医学版), 2021, 41(8): 1120-1124.
[11]	程盛, 赵益, 王永琛, 黄平. BRAF基因突变对肝切除后的结直肠癌肝转移患者预后影响的meta分析[J]. 上海交通大学学报(医学版), 2021, 41(6): 786-792.
[12]	包汝娟, 陈慧芳, 董宇, 叶幼琼, 苏冰. 基于转录组异常表达构建结直肠癌特征基因预后风险评分模型[J]. 上海交通大学学报(医学版), 2021, 41(3): 285-296.
[13]	马燕如, 季林华, 童天颖, 严宇青, 沈超琴, 张昕雨, 曹颖颖, 洪洁, 陈豪燕. 基于单细胞RNA测序的结直肠癌预后预测模型的建立和验证[J]. 上海交通大学学报(医学版), 2021, 41(2): 159-165.
[14]	傅中懋, 罗再, 戎泽印, 章建明, 李腾飞, 余志龙, 黄陈. 基于高通量测序的结直肠癌组织中环状RNA功能研究与预后分析[J]. 上海交通大学学报(医学版), 2021, 41(2): 187-195.
[15]	林梁俊, 王卫娣, 王佩, 林关宁, 王振. 强迫症的表观遗传学研究进展[J]. 上海交通大学学报(医学版), 2021, 41(2): 267-272.